Insider Selling: HCA Healthcare, Inc. (NYSE:HCA) Insider Sells 2,900 Shares of Stock

HCA Healthcare, Inc. (NYSE:HCAGet Free Report) insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

HCA Healthcare Trading Down 0.7 %

Shares of NYSE HCA opened at $342.96 on Friday. The company’s fifty day moving average is $385.11 and its 200-day moving average is $357.58. The stock has a market cap of $86.87 billion, a price-to-earnings ratio of 15.40, a P/E/G ratio of 1.34 and a beta of 1.68. HCA Healthcare, Inc. has a twelve month low of $238.82 and a twelve month high of $417.14. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.77%. HCA Healthcare’s dividend payout ratio is 11.85%.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on HCA. KeyCorp dropped their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a report on Tuesday, October 1st. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. TD Cowen dropped their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday, October 28th. Finally, Royal Bank of Canada raised their price objective on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. Five analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $385.00.

Check Out Our Latest Research Report on HCA

Hedge Funds Weigh In On HCA Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. MFA Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare during the second quarter worth $27,000. Unique Wealth Strategies LLC acquired a new stake in HCA Healthcare in the 2nd quarter valued at $28,000. Bangor Savings Bank increased its stake in HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after buying an additional 45 shares during the last quarter. GPS Wealth Strategies Group LLC increased its stake in shares of HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares during the last quarter. Finally, Legacy Investment Solutions LLC acquired a new position in shares of HCA Healthcare during the 3rd quarter worth about $39,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Company Profile

(Get Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.